These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27818010)

  • 1. The gross motor function measure is valid for Fukuyama congenital muscular dystrophy.
    Sato T; Adachi M; Nakamura K; Zushi M; Goto K; Murakami T; Ishiguro K; Shichiji M; Saito K; Ikai T; Osawa M; Kondo I; Nagata S; Ishigaki K
    Neuromuscul Disord; 2017 Jan; 27(1):45-49. PubMed ID: 27818010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A short form of gross motor function measure for Fukuyama congenital muscular dystrophy.
    Sato T; Adachi M; Matsuo A; Zushi M; Goto K; Hirose M; Ishiguro K; Shichiji M; Murakami T; Ikai T; Osawa M; Kondo I; Nagata S; Ishigaki K
    Brain Dev; 2020 May; 42(5):383-388. PubMed ID: 32145987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary titin as a biomarker in Fukuyama congenital muscular dystrophy.
    Sato T; Awano H; Ishiguro K; Shichiji M; Murakami T; Shirakawa T; Matsuo M; Nagata S; Ishigaki K
    Neuromuscul Disord; 2021 Mar; 31(3):194-197. PubMed ID: 33563515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National registry of patients with Fukuyama congenital muscular dystrophy in Japan.
    Ishigaki K; Ihara C; Nakamura H; Mori-Yoshimura M; Maruo K; Taniguchi-Ikeda M; Kimura E; Murakami T; Sato T; Toda T; Kaiya H; Osawa M
    Neuromuscul Disord; 2018 Oct; 28(10):885-893. PubMed ID: 30220444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Central Nervous Involvement in Patients with Fukuyama Congenital Muscular Dystrophy].
    Ishigaki K
    Brain Nerve; 2016 Feb; 68(2):119-27. PubMed ID: 26873231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute rhabdomyolysis following viral infection with coxsackie A4 in a 50-day-old infant with Fukuyama congenital muscular dystrophy.
    Yamaguchi H; Taniguchi-Ikeda M; Nagase H; Ito Y; Tokumoto S; Toyoshima D; Enkhjargal S; Nishiyama M; Awano H; Kurosawa H; Kasai M; Maruyama A; Iijima K
    J Infect Chemother; 2020 May; 26(5):516-519. PubMed ID: 31983616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac involvement in Fukuyama muscular dystrophy is less severe than in Duchenne muscular dystrophy.
    Yamamoto T; Taniguchi-Ikeda M; Awano H; Matsumoto M; Lee T; Harada R; Imanishi T; Hayashi N; Sakai Y; Morioka I; Takeshima Y; Iijima K; Saegusa J; Toda T
    Brain Dev; 2017 Nov; 39(10):861-868. PubMed ID: 28578814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory management of patients with Fukuyama congenital muscular dystrophy.
    Sato T; Murakami T; Ishiguro K; Shichiji M; Saito K; Osawa M; Nagata S; Ishigaki K
    Brain Dev; 2016 Mar; 38(3):324-30. PubMed ID: 26363734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leigh syndrome with Fukuyama congenital muscular dystrophy: a case report.
    Kondo H; Tanda K; Tabata C; Hayashi K; Kihara M; Kizaki Z; Taniguchi-Ikeda M; Mori M; Murayama K; Ohtake A
    Brain Dev; 2014 Sep; 36(8):730-3. PubMed ID: 24113355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutation in the fukutin gene in an Egyptian family with Fukuyama congenital muscular dystrophy and microcephaly.
    Ismail S; Schaffer AE; Rosti RO; Gleeson JG; Zaki MS
    Gene; 2014 Apr; 539(2):279-82. PubMed ID: 24530477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy.
    Murakami T; Sato T; Adachi M; Ishiguro K; Shichiji M; Tachimori H; Nagata S; Ishigaki K
    Sci Rep; 2021 Dec; 11(1):24229. PubMed ID: 34930981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Portuguese case of Fukuyama congenital muscular dystrophy caused by a multi-exonic duplication in the fukutin gene.
    Costa C; Oliveira J; Gonçalves A; Santos R; Bronze-da-Rocha E; Rebelo O; Pais RP; Fineza I
    Neuromuscul Disord; 2013 Jul; 23(7):557-61. PubMed ID: 23582336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe muscle damage following viral infection in patients with Fukuyama congenital muscular dystrophy.
    Murakami T; Ishigaki K; Shirakawa S; Ikenaka H; Sakauchi M; Osawa M
    Brain Dev; 2012 Apr; 34(4):293-7. PubMed ID: 21726969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the upper limb muscles in patients with Fukuyama muscular dystrophy: Noninvasive assessment using visual ultrasound muscle analysis and shear wave elastography.
    Harada R; Taniguchi-Ikeda M; Nagasaka M; Nishii T; Inui A; Yamamoto T; Morioka I; Kuroda R; Iijima K; Nozu K; Sakai Y; Toda T
    Neuromuscul Disord; 2022 Sep; 32(9):754-762. PubMed ID: 35902324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristic Cochlear Hypoplasia in Patients with Walker-Warburg Syndrome: A Radiologic Study of the Inner Ear in α-Dystroglycan-Related Muscular Disorders.
    Talenti G; Robson C; Severino MS; Alves CA; Chitayat D; Dahmoush H; Smith L; Muntoni F; Blaser SI; D'Arco F
    AJNR Am J Neuroradiol; 2021 Jan; 42(1):167-172. PubMed ID: 33122211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Founder mutation causes classical Fukuyama congenital muscular dystrophy (FCMD) in Chinese patients.
    Yang H; Kobayashi K; Wang S; Jiao H; Xiao J; Toda T; Wu X; Xiong H
    Brain Dev; 2015 Oct; 37(9):880-6. PubMed ID: 25814170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental changes of radiological findings in Fukuyama-type congenital muscular dystrophy.
    Kato Z; Morimoto M; Orii KE; Kato T; Kondo N
    Pediatr Radiol; 2010 Dec; 40 Suppl 1():S127-9. PubMed ID: 20571791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotype-phenotype correlation in Fukuyama congenital muscular dystrophy.
    Saito K; Osawa M; Wang ZP; Ikeya K; Fukuyama Y; Kondo-Iida E; Toda T; Ohashi H; Kurosawa K; Wakai S; Kaneko K
    Am J Med Genet; 2000 May; 92(3):184-90. PubMed ID: 10817652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep-intronic variant of fukutin is the most prevalent point mutation of Fukuyama congenital muscular dystrophy in Japan.
    Kobayashi K; Kato R; Kondo-Iida E; Taniguchi-Ikeda M; Osawa M; Saito K; Toda T
    J Hum Genet; 2017 Nov; 62(11):945-948. PubMed ID: 28680109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular manifestations in Fukuyama type congenital muscular dystrophy.
    Yoshioka M; Kuroki S; Kondo T
    Brain Dev; 1990; 12(4):423-6. PubMed ID: 2240463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.